OPEN-SCS plug fest took place in Lüneburg on invitation of Werum IT Solutions / Successful testing of interfaces, interoperability, and compliance adherence / OPEN-SCS honored with Pharma 4.0 Award Lüneburg, Germany, 17 October 2019 – OPEN-SCS and Werum IT Solutions successf … Read More »

London, 17th October 2019: CPhI Worldwide announces the finalists for the CPhI Pharma Awards. The shortlist spans 13 different categories across the full spectrum of the pharmaceutical supply chain, including Formulation, Packaging and Lifetime Achievement Awards. The winner … Read More »

AstraZeneca have announced that the US FDA has granted Priority Review for its experimental breast cancer treatment trastuzumab. The Prescription Drug User Fee Fact (PDUFA) date for trastuzumab deruxtecan, an HER-2 targeting antibody drug conjugate and potential new medicine … Read More »

The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division Sandoz announced that it is handing sole responsibility for the commercialization of the reSET and reSET-O prescription digital therapeutics back to Pear Therapeutics. … Read More »

Alexion has struck a deal to buy Achillion for $930 million upfront. The takeover will give Alexion two clinical-phase medicines in development in complement alternative pathway-mediated rare diseases. Achillion, once a high-flying hepatitis C player, is now focused on the d … Read More »

Acquisition increases BioIVT’s access to normal and disease-state leukopaks, plasma and sera, and expands its cell processing capabilities   BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired P … Read More »

 The most influential scientific research consortium of its kind: 37 biopharmaceutical companies work in a pre-competitive environment to advance PBPK modeling and simulation, progress new drug and biologics research, create new regulatory frontiers, foster ongoing modeling … Read More »

Deliveries of the vital childhood cancer drug vincristine, which is currently in very short supply across the U.S. should resume in late October, according to a new statement from the FDA. However, the drug is still predicted to be in short supply until at least December, in … Read More »

Hisamitsu Pharmaceutical subsidiary Noven Pharmaceuticals has revealed the FDA approval of Secuado (asenapine) in adult schizophrenia patients, making it the first and only transdermal patch formulation available in the US for the treatment of the condition. Applied daily, t … Read More »

Blueprint Medicines will receive $25 million to collaborate with the French drug maker Ipsen on a potential medical treatment that the Cambridge biotech has developed for an ultra-rare genetic disease. The licensing deal marks the fourth collaboration between Blueprint — fou … Read More »

Three major drug distributors are in talks to pay $18 billion to settle sweeping litigation brought by state and local governments blaming them for fueling the opioid crisis, people familiar with the discussions said, potentially marking a broad resolution to lawsuits that h … Read More »

The Prestigious UK Academic Institution selected TrialConsent® to Administer eConsent to Benefit Sites and Patients in Future Clinical Research The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) at the University of Bristol has s … Read More »

Basel, Switzerland, October 14, 2019 – Lonza today announced an extension to its partnership with Genmab to cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline. Lonza’s Ibex Solutions in Visp (CH) is designed to provide … Read More »

DUBLIN, Oct. 14, 2019 /PRNewswire/ — NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) (the “Comp … Read More »

World ADC is pleased to announce the winners at the 6th Annual World ADC Awards Now in its 6th year, the World ADC Awards showcases the innovation, leadership and devotion shown by the best companies, teams and individuals in the industry. Across 9 categories the Awards reco … Read More »

(Winnipeg, Manitoba, October 11, 2019) – Bioscience Association Manitoba is pleased to announce the fifth edition of Funding Day. This one-day conference will be held on November 13, 2019, at Victoria Inn Hotel & Convention Centre (1808 Wellington Ave, Winnipeg) Funding … Read More »

INDIANAPOLIS, Oct. 11, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of migraine, with or without aura, in adults. RE … Read More »

Sensyne has announced a new partnership – its second this week – with Bayer, in order to accelerate the development of new treatments using clinical artificial intelligence. The company revealed that it will work in partnership with the German pharma giant on novel projects … Read More »

—Scott Asher joins as Chief Development Officer; Former CityMD Legal Counsel, Claudia Hinrichsen, brings legal expertise to HPM— UNIONDALE, N.Y.–(BUSINESS WIRE)–Health Plus Management, a physician support organization (PSO) providing business management and operations serv … Read More »

Winston-Salem, N.C.; Oct 10, 2019 (Business Wire) – Clinical Ink, a global clinical trial technology company that is transforming the clinical trial experience, is pleased that the European Medicines Agency (EMA) has signaled its support of eSource direct data capture (DDC) … Read More »